Searched for
FDA LEADERSHIP
Trump picks Heidi Overton to run Food and Drug Administration, Bloomberg News reportsPresident Donald Trump has chosen Heidi Overton to lead the Food and Drug Administration. Overton currently serves as deputy director of th...- India's pharma sector must shift from cost competitiveness to innovation, global quality: ExpertsFor the growth of India's pharmaceutical sector, prioritizing innovation and advanced manufacturing is essential. Experts indicate that inc...
- Independence Day 2026: India, which once couldn't make smallpox vaccine, has now crossed a pharma milestone the world can't ignore2026 Independence Day: India's pharmaceutical industry marks a historic milestone with a new drug approval. This achievement reflects decad...
- CNN SSRS Poll: Trump's approval ratings crash to one of the lowest in his political journey, why?CNN SSRS Poll: President Trump's approval rating has fallen to a career low of thirty-four percent. Americans are increasingly dissatisfied...
- How to Articulate Your Contributions as a Senior LeaderThe higher you rise, the tricker it gets to talk about your wins. You’re often not the one building the financial model, writing the code, ...
- Match Your AI Strategy to Your Organization’s RealityArtificial intelligence is often hailed as a game changer, but too many firms discover that their bold AI pilots collapse when their operat...
- Why CDSCO and BEE have not kept pace with the industries they overseeCDSCO still faces challenges like chronic understaffing, gaps in technical skills, weak lab infra and fragmented approvals. About a decade ...
- Biosimilars and innovation will drive Indian pharma's next growth phase: Vishal ManchandaIndia's pharmaceutical sector is pivoting beyond generics, with companies aggressively pursuing growth in biosimilars, nutraceuticals, and ...
- FDA drug center head fired after commissioner's exit, replaced by DavisThe U.S. Food and Drug Administration's drug center sees a leadership change as acting head Tracy Beth Hoeg departs, replaced by deputy Mic...
- US FDA to fast-track nicotine pouch reviews amid pressure from Trump administrationThe US Food and Drug Administration will expedite reviews for nicotine pouches from four tobacco firms. This pilot program starts on Monday...
- Vinay Prasad, US FDA's chief medical and science officer, departs agencyVinay Prasad, the Food and Drug Administration's chief medical and science officer, resigned. He cited a desire to return to California and...
- Indian-American Vinay Prasad takes charge as US vaccine chiefVinay Prasad, an oncologist-hematologist, has been appointed as the new director of the FDA's CBER, overseeing vaccines and genetic medicin...
- Bakul Patel joins the board of Digital Health AssociatesPatel has a 13-year tenure at the US FDA and has contributed to transforming the healthcare industry and mainstreaming digital health.
- Market downbeat on pharma top picks – Sun Pharma and Dr. Reddy’sDr. Reddy’s informed stock exchanges that 3 of its key sites received warning letters from US FDA and will need to submit correction plans ...
- Make quality top priority: USFDA to Indian pharma companiesThe sites of leading drugmakers such as Ranbaxy Laboratories, Wockhardt, Strides Arcolab and Sun Pharma are on the USFDA list.
- US FDA asks Indian pharma leaders to make quality, their top priority"Companies must ensure that they are saying what they do and they do what they say and demonstrate that they did it" said Leslie Ball of FD...
- Only a multi-skilled engineer can drive corruption and sloth-riddled Indian government institutionsTo do public policy in India, the skill required is that of an engineer and not the driver. It is about opening the hood, understanding wha...
- Can one draw parallels with Ranbaxy's case and Wockhardt?US FDA raising issues questioning the company’s integrity and transparency are likely to have long term ramifications on its oversees busin...
- Daiichi to meet US FDA to resolve Ranbaxy issueDaiichi Sankyo, the Japanese pharmaceutical company that bought Ranbaxy Laboratories last year, will meet US FDA officials next month to so...
- Safety scare over Glaxo drug fuels talks of tougher laws in USLaw makers are seizing on last month’s study linking GlaxoSmithKline’s diabetes drug Avandia and heart risks to press for new US drug-safet...
Load More
